Posted on 9/4/18
OncoSec Raises $15M From Alpha Holdings
OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, today announced that it has secured a $15 million
Posted on 9/4/18
Recro Pharma Provides Regulatory Update for IV Meloxicam
MALVERN, Pa., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other . . .
Posted on 9/4/18
Celgene Vs. AbbVie: The 2 Cheapest Large Cap Pharma Stocks
SummaryFor 2018, both Celgene and AbbVie expect approximately 15% revenue growth.Both Celgene and AbbVie have low PEG ratios of 0.54x and 0.76x, respectively.Wall Street is more . . .
Posted on 9/4/18
Amneal Announces Partnership with American Regent on Generic Makena
Amneal Pharmaceuticals, Inc. (NYSE: AMRX), a specialty pharmaceutical company, today announced a 5-year supply and distribution agreement with American Regent for the only preservative-free generic alternative . . .
Posted on 8/31/18
Better Buy: Johnson & Johnson vs. Merck
Few industries have the breadth that investors can find in healthcare. Those with a speculative bent can choose drug developers with no sales and only the . . .
Posted on 8/31/18
Capital Health Regional Medical Center Recognized as Top Hospital for Neurology and Neurosurgery
Capital Health Regional Medical Center (RMC), was recently recognized as the best hospital for Neurology and Neurosurgery in the Region in U.S. News & World Report . . .
Posted on 8/30/18
Otsuka Announces First Collaboration Agreement
PRINCETON, N.J.--(BUSINESS WIRE)--Otsuka America Pharmaceutical, Inc. (Otsuka) announced today that it has signed a Collaboration Agreement to facilitate access to the ABILIFY MYCITE System to select . . .
Posted on 8/30/18
Is Celgene Corporation a Buy?
It's best that I acknowledge that right out of the gate. I've owned Celgene Corporation(NASDAQ:CELG) stock for several years. I've seen it go up, and I've . . .
Posted on 8/29/18
Pfizer (PFE) Investor Presentation - Slideshow
The following slide deck was published by Pfizer Inc. in conjunction with this event. 117READ FULL ARTICLE HERE
Posted on 8/29/18
Johnson & Johnson (JNJ) Updates on Mariner & Commander HF Clinical Trial Results - Slideshow
The following slide deck was published by Johnson & Johnson in conjunction with this event. 124READ FULL ARTICLE HERE
Posted on 8/29/18
Pfizer Achieves Success In Rare Heart Disease Study
SummaryPfizer obtains positive results in a phase 3 study treating patients with Transthyretin Cardiomyopathy using Tafamidis.Patients treated with Tafamidis were able to reduce the risk of . . .
Posted on 8/29/18
Pfizer's Tafamidis Will Be Standard Of Care For A Not-So-Rare Disease
SummaryDrugs that are shown to improve survival quickly become standard of care.Tafamidis is the only drug known to improve survival in transthyretin-related (TTR) cardiac amyloidosis and . . .
Posted on 8/29/18
Johnson & Johnson Is Hiring -- and It's Ginormous News for Geron
It's possible that a new job posting has never been as important to a small biotech as this one. And it's highly probable that no reference . . .
Posted on 8/29/18
6 Things Alnylam Investors Need to Know About Pfizer's Next Blockbuster Drug
After 16 years as a public company, Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) finally got the go-ahead to launch its first product earlier this month. Onpattro is the . . .
Posted on 8/28/18
CitiusTech Makes Strategic Investment in FluidEdge Consulting
PRINCETON, N.J.--(BUSINESS WIRE)--CitiusTech, a leading provider of healthcare technology solutions and services, announced today that it has made a strategic investment in FluidEdge Consulting (FluidEdge), a . . .
Posted on 8/28/18
Biotech Analysis Central Pharma News: J&J And Bayer Failure, Gilead Sciences Unloads Cancer Drug, Mallinckrodt Fails To Get Green Light
SummaryJ&J and Bayer fail to improve prospects for blood clot drug after trial results.Gilead Sciences offloads late-stage drug for myelofibrosis.Mallinckrodt suffers huge blow as FDA rejects . . .
Posted on 8/27/18
Better Buy: Intuitive Surgical, Inc. vs. Johnson & Johnson
At first glance, Intuitive Surgical (NASDAQ:ISRG) and Johnson & Johnson (NYSE:JNJ)might seem to have little in common other than they both sell medical instruments. However, Johnson . . .
Posted on 8/26/18
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on August 22, 2018 it approved non-statutory stock options to purchase an aggregate of 381,500 shares of its . . .
Posted on 8/24/18
Johnson & Johnson Buried Key Facts On Faulty Hip Implant Surgeries - IndianExpress
The Indian Express reports that the Indian arm of Johnson & Johnson (NYSE:JNJ) suppressed key facts on the harmful aftermath of surgeries conducted on hundreds of . . .
Posted on 8/23/18
Immunomedics Provides Corporate Update
MORRIS PLAINS, N.J., Aug. 23, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (NASDAQ:IMMU), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today reported financial . . .
Posted on 8/23/18
Eagle Pharmaceuticals Named to Fortune 100 List of Fastest-Growing Companies
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) today announced that the Company has been named to the Fortune 100 List of Fastest-Growing Companies, ranking 16thoverall, including . . .
Posted on 8/23/18
Merck Obtains Earlier FDA Approval For Expanded Label Of Keytruda In Front-Line Lung Cancer
SummaryMerck obtains expanded FDA approval for Keytruda combination treating front-line patients with non-squamous non-small cell lung cancer.The Keytruda combination proved to reduce the risk of death . . .
Posted on 8/23/18
Better Buy: GlaxoSmithKline PLC vs. Pfizer
GlaxoSmithKline PLC (NYSE:GSK) and Pfizer (NYSE:PFE) are both on track for record-breaking years in terms of their share-price performance. Glaxo's shares have turned sharply higher this . . .
Posted on 8/22/18
Vitals Earns Place on NJBIZ Top 250 Privately Held Companies List
LYNDHURST, N.J.--(BUSINESS WIRE)--Vitals, the company that empowers consumers to shop for their health care like an expert, announces its inclusion in the 2018 NJBIZ Top 250 . . .
Posted on 8/22/18
Pfizer Stock Just Hit a 10-Year High: Buy, Sell, or Hold?
Who would have thunk it? Pfizer (NYSE:PFE) stock is trouncing the S&P 500 index so far in 2018. That's right, shares of the 168-year-old drugmaker have . . .

